SCHEMBL7230885

SCHEMBL7230885

C[SiH](C)OCc1ccnc(-c2cccc(N)c2)c1C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
MEN1 O00255 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CDK5 Q00535 1/20 0.34
KMT2A Q03164 1/20 0.34
CDK5R1 Q15078 1/20 0.34
MAP4K4 O95819 5/20 0.33
KARS1 Q15046 1/20 0.33
PLK1 P53350 1/20 0.33
GRM5 P41594 1/20 0.33
PSIP1 O75475 1/20 0.32
AXL P30530 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
AURKA O14965 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232521 0.81 PDE4D (0.46) MEN1KMT2APLK1
SCHEMBL7230490 0.79 MAP4K4 (0.35) MEN1NPC1RAB9ACDK5KMT2A
SCHEMBL7847202 0.74
SCHEMBL7504270 0.71
SCHEMBL6967477 0.70
SCHEMBL10623645 0.67 MAOB (0.47) CYP3A4CYP19A1ALDH1A1MAOBMAOA
SCHEMBL7230890 0.66 MAP4K4 (0.40) MEN1NPC1MAP4K4PSIP1AXL
SCHEMBL21805721 0.62 MAP4K4 (0.51) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL30087906 0.62 MAP4K4 (0.51) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL10361549 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed